SLEEP 2024

SLEEP 2024 | A Cross-Border Conference To Promote A New Future For Global Sleep Technology With Professionalism

After successfully participating in the Hospitalar exhibition in Brazil in May, SunnyGrand traveled to Houston, USA in early June and made a splash at the Global Sleep Conference (SLEEP 5). This time, SunnyGrand shined at the event with its annual new products, the innovative automatic titration ventilator, the NatrComfy series masks and the Natr™ series sleep breathing ecosystem, attracting the attention of the audience and winning high recognition from sleep breathing clinical and field-related experts, scholars and industry peers from all over the world.

At the conference, many world-class sleep clinical experts and nearly 5000 professionals gathered to exchange, research and share new achievements, new progress and new technologies in the field of sleep. During the conference, the SunnyGrand team showed and demonstrated its multi-dimensional, three-dimensional and comprehensive sleep breathing ecological comprehensive solution to the audience. The sleep breathing products contained in this solution from monitoring to diagnosis, from treatment to rehabilitation are not only a major technological breakthrough, but also a further optimization and upgrade close to the user experience. SunnyGrand strives to provide patients with more comfortable and doubly efficient treatment equipment and services, so as to jointly promote the high-quality development of global sleep health.

At the event, Professor Han Fang and Professor Zhang Xilong from my country, as well as internationally renowned leading experts from Europe, America, Asia-Pacific, Africa and other regions, all expressed their appreciation for SunnyGrand's innovative achievements. Praises such as "impressive" and "game changer" were heard everywhere. Experts unanimously believed that SunnyGrand's products not only achieved technological leadership, but also had sufficient competitiveness and huge market potential in the global market. In addition, industry partners also showed great interest in SunnyGrand's technology and products, believing that SunnyGrand's participation has injected new vitality and new hope into the field of sleep apnea.

SLEEP 2024 aims to guide the development of global sleep research and practice, aggregate the forces of industry, academia and research to jointly break through key technical difficulties in sleep clinical practice, accelerate the sharing and transformation of the latest scientific research results, and achieve win-win cooperation among multiple parties.

Sleep breathing disorders are a group of diseases characterized by abnormal breathing rhythm and ventilation function during sleep, including obstructive sleep apnea hypopnea syndrome (OSAHS), central sleep apnea syndrome (CSAS), sleep-related hypoventilation disease (SHVD), sleep-related hypoxemia, single syndrome and normal variants (snoring and night groaning). According to statistics from The Lancet in 2019, there are nearly 10 billion OSA (sleep apnea) patients worldwide. For sleep disorders with multiple factors and multiple lesions, we must prevent, diagnose and treat them early.

Faced with challenges such as an aging population, younger people suffering from sleep respiratory diseases, and low patient awareness, it also requires the joint efforts of multiple roles such as global sleep clinics, the sleep industry, and consumer market players to continuously promote the stable and sustainable development of sleep health through academic sharing, talent training, technological innovation, and health education. Strengthening international cooperation and exchanges and making full use of new technologies to promote market development will build a better future for the sleep respiratory health market for you and me.

After the accumulation of informatization and AI technology in global medical care, the sleep apnea sub-industry finally gave birth to an ecological model with the system as the core, coordinated with the three elements of algorithm, computing power and data. However, due to the rigor, real-time, data sensitivity and complexity of medical care itself, generative artificial intelligence has a more profound and broad journey in the mature application of medical equipment in hospitals or homes and other scenarios.

This time, SunnyGrand’s successful appearance at the Houston Global Sleep Conference not only demonstrated its strong innovation capabilities and market potential to the audience, but also marked a major leap for the brand into the international market, further consolidating the solid foundation for the company’s future international development.

The healthy development of the global sleep respiratory product ecosystem requires the joint participation of multiple roles such as clinical physicians, scientific researchers, equipment R&D, manufacturing and marketing service providers. As a sleep respiratory ecosystem product developer and manufacturer, SunnyGrand will continue to keep up with the latest trends in the sleep medicine market, accelerate product technology iteration and upgrades, and accelerate the transformation of clinical results. In addition, SunnyGrand will continue to work together with global clinical and field professionals and industry colleagues to promote the development of sleep health, persevere in popularizing the concept of sleep respiratory health, and allow the risks of sleep respiratory chronic diseases to be seen, valued, and prevented earlier, and meet people's higher demands for health and quality of life with modern and intelligent precision medicine.